Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis (SONIC)
This study is currently recruiting participants.
Study NCT00629642 Information provided by Astellas Pharma Inc
First Received: February 26, 2008 Last Updated: November 2, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neurogenic Bladder
Spinal Cord Diseases
Multiple Sclerosis
Additional conditions recognized in this trial
Nerve Compression Syndromes
Sclerosis
Urinary Bladder, Neurogenic
More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Central Nervous System Diseases
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Pathologic Processes
Peripheral Nervous System Diseases
Signs and Symptoms
Urinary Bladder Diseases
Urologic Diseases
Interventions listed in this trial
Solifenacin Succinate
Oxybutynin Hydrochloride
Placebo
Additional drug interventions recognized in this trial
Mandelic Acids
Oxybutynin
Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Infective Agents, Urinary
Autonomic Agents
Cholinergic Agents
Cholinergic Antagonists
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
Astellas Pharma Inc
Back to top of Main Content
